BREZTRI AEROSPHERE

Peak

budesonide, glycopyrrolate, and formoterol fumarate

NDAINHALATIONAEROSOL, METERED
Approved
Jul 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1

Mechanism of Action

Corticosteroid Hormone Receptor Agonists

Pharmacologic Class:

Corticosteroid

Clinical Trials (1)

NCT06531798Phase 4Not Yet Recruiting

Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease

Started Dec 2025
150 enrolled
Moderate to Severe COPD

Loss of Exclusivity

LOE Date
Oct 5, 2038
153 months away
Patent Expiry
Oct 5, 2038

Patent Records (5)

Patent #ExpiryTypeUse Code
9463161
May 28, 2030
Product
U-2889
8808713
May 28, 2030
Product
U-2889
9415009
May 28, 2030
U-2889
10716753
May 28, 2030
Product
U-2889
8324266
May 28, 2030
U-2889